goto Indian Health Service home page  Indian Health Service:  The Federal Health Program for American Indians and Alaska Natives

 
IHS HOME ABOUT IHS SITE MAP HELP
goto Health and Human Services home page goto Health and Human Services home page
Other Areas of Interest:

Mature Women Topics

Contact Us

WH Web Administrator

Required Plugins

These plug-ins
may be required
for the content
on this page:


Link to Adobe Acrobat Plug-in Acrobat
Link to MicroSoft Word Plug-in MS Word

IHS Plug-in Page

Use site contact
if unable to view
a particular file

Women's Health

Women's Health ‹ Menopause Management

Mature Women

Menopause Management

FDA Estrogen and Estrogen with Progestin Therapies

Report of NIH Scientific Workshop: Menopausal Hormone Therapy

Are you confused about what is a natural, plant, synthetic, or phytoestrogen source of hormones?

Return to top of page

Postmenopausal Hormone Therapy and Breast Cancer

  • Editorial, by Dan Mishell, MD National American Menopause Society Newsletter WORD (20k)

FDA approved a lower dose single tablet of Prempro

WHI: Effects of Estrogen plus Progestin on Health-Related Quality of Life

Return to top of page

Hormone Replacement Therapy Use Among Postmenopausal Women in US

Hot Flash-Menu: Frequently asked questions

  • Great resource for 'natural' vs 'plant' vs other sources of hormones

Women's Health Initiative

Return to top of page

ITU Sample HRT letter for patients

To be sent to all patients on HRT to encourage a visit to discuss hormone replacement therapy Word Version (23k) Html Version (14k)

Sample patient HRT handout

Intro: Courtesy of Providence Health Care Systems Word Version (23k) Html Version (12k) Adobe PDF version (94k)

Return to top of page

Sample PCC overlay

This document outlines the risks/benefits that should be discussed with each patient Word version (27k) Html version (9k)

Natt Cobb's presentation at the 2002 OB/GYN Biennial meeting on the WHI and AI/AN Epidemiology

   

Note: slides 40 - 44 have estimated rates of AI/AN CVD, colorectal, ovarian, and breast cancer. PowerPoint Version (449k) and online Powerpoint Version with index (139k)

Return to top of page

Clinical reviews of Hormone Replacement Therapy from UpToDate.

ACOG Statement on the Estrogen Plus Progestin Trial of The Women's Health Initiative

Long term HRT patients should consult their provider. No changes for short term HRT user

NHLBI Stops Trial of Estrogen Plus Progestin Due to Increased Breast Cancer Risk, Lack of Overall Benefit

NLM Clinical Alert

Return to top of page

Feedback: Women's Health Web Administrator

This file last modified: Thursday December 27, 2007  5:46 AM